318 related articles for article (PubMed ID: 18369062)
1. The effect of sildenafil on ocular blood flow.
Harris A; Kagemann L; Ehrlich R; Ehrlich Y; López CR; Purvin VA
Br J Ophthalmol; 2008 Apr; 92(4):469-73. PubMed ID: 18369062
[TBL] [Abstract][Full Text] [Related]
2. The effects of sildenafil on ocular blood flow.
Koksal M; Ozdemir H; Kargi S; Yesilli C; Tomaç S; Mahmutyazicioglu K; Mungan A
Acta Ophthalmol Scand; 2005 Jun; 83(3):355-9. PubMed ID: 15948790
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil (Viagra) evokes retinal arteriolar dilation: dual pathways via NOS activation and phosphodiesterase inhibition.
Yuan Z; Hein TW; Rosa RH; Kuo L
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):720-5. PubMed ID: 18235020
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil and ocular perfusion.
Sponsel WE; Paris G; Sandoval SS; Sanford DK; Harrison JM; Elliott WR; Trigo Y
N Engl J Med; 2000 Jun; 342(22):1680. PubMed ID: 10836891
[No Abstract] [Full Text] [Related]
5. Phosphodiesterase type 5 inhibition reverses impaired forearm exercise-induced vasodilatation in hypertensive patients.
Attinà TM; Malatino LS; Maxwell SR; Padfield PL; Webb DJ
J Hypertens; 2008 Mar; 26(3):501-7. PubMed ID: 18300861
[TBL] [Abstract][Full Text] [Related]
6. The cyclic GMP-specific phosphodiesterase inhibitor, sildenafil, stimulates human sperm motility and capacitation but not acrosome reaction.
Lefièvre L; De Lamirande E; Gagnon C
J Androl; 2000; 21(6):929-37. PubMed ID: 11105920
[TBL] [Abstract][Full Text] [Related]
7. Relaxation and cyclic GMP levels in response to sildenafil in human pulmonary arteries from donors.
Mauricio MD; Segarra G; Medina P; Aldasoro M; Martínez-León JB; Vila JM
Eur J Pharmacol; 2006 Jan; 530(3):259-62. PubMed ID: 16380114
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil inhibits the up-regulation of phosphodiesterase type 5 elicited with nicotine and tumour necrosis factor-alpha in cavernosal vascular smooth muscle cells: mediation by superoxide.
Hotston MR; Jeremy JY; Bloor J; Koupparis A; Persad R; Shukla N
BJU Int; 2007 Mar; 99(3):612-8. PubMed ID: 17176295
[TBL] [Abstract][Full Text] [Related]
9. The effect of sildenafil on nitric oxide-mediated vasodilation in healthy men.
Dishy V; Sofowora G; Harris PA; Kandcer M; Zhan F; Wood AJ; Stein CM
Clin Pharmacol Ther; 2001 Sep; 70(3):270-9. PubMed ID: 11557915
[TBL] [Abstract][Full Text] [Related]
10. Effects of sildenafil on retinal blood flow and flicker-induced retinal vasodilatation in healthy subjects.
Polak K; Wimpissinger B; Berisha F; Georgopoulos M; Schmetterer L
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4872-6. PubMed ID: 14578411
[TBL] [Abstract][Full Text] [Related]
11. The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects.
Kruuse C; Thomsen LL; Jacobsen TB; Olesen J
J Cereb Blood Flow Metab; 2002 Sep; 22(9):1124-31. PubMed ID: 12218418
[TBL] [Abstract][Full Text] [Related]
12. Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease.
Ravipati G; McClung JA; Aronow WS; Peterson SJ; Frishman WH
Cardiol Rev; 2007; 15(2):76-86. PubMed ID: 17303994
[TBL] [Abstract][Full Text] [Related]
13. PDE5 inhibitor sildenafil citrate augments endothelium-dependent vasodilation in smokers.
Kimura M; Higashi Y; Hara K; Noma K; Sasaki S; Nakagawa K; Goto C; Oshima T; Yoshizumi M; Chayama K
Hypertension; 2003 May; 41(5):1106-10. PubMed ID: 12695418
[TBL] [Abstract][Full Text] [Related]
14. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.
Jaillard S; Larrue B; Deruelle P; Delelis A; Rakza T; Butrous G; Storme L
Ann Thorac Surg; 2006 Mar; 81(3):935-42. PubMed ID: 16488698
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil-mediated reduction in retinal function in heterozygous mice lacking the gamma-subunit of phosphodiesterase.
Behn D; Potter MJ
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):523-7. PubMed ID: 11157892
[TBL] [Abstract][Full Text] [Related]
16. The effect of sildenafil on the altered thoracic aorta smooth muscle responses in rat pre-eclampsia model.
Turgut NH; Temiz TK; Bagcivan I; Turgut B; Gulturk S; Karadas B
Eur J Pharmacol; 2008 Jul; 589(1-3):180-7. PubMed ID: 18538317
[TBL] [Abstract][Full Text] [Related]
17. Sildenafil: emerging cardiovascular indications.
Raja SG; Nayak SH
Ann Thorac Surg; 2004 Oct; 78(4):1496-506. PubMed ID: 15464535
[TBL] [Abstract][Full Text] [Related]
18. Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil.
Melenovsky V; Al-Hiti H; Kazdova L; Jabor A; Syrovatka P; Malek I; Kettner J; Kautzner J
J Am Coll Cardiol; 2009 Aug; 54(7):595-600. PubMed ID: 19660688
[TBL] [Abstract][Full Text] [Related]
19. Short- and long-term effects of sildenafil on skin flap survival in rats.
Hart K; Baur D; Hodam J; Lesoon-Wood L; Parham M; Keith K; Vazquez R; Ager E; Pizarro J
Laryngoscope; 2006 Apr; 116(4):522-8. PubMed ID: 16585853
[TBL] [Abstract][Full Text] [Related]
20. The association between intron 4 VNTR, E298A and IVF 23+10 G/T polymorphisms of ecNOS gene and sildenafil responsiveness in patients with erectile dysfunction.
Peskircioglu L; Atac FB; Erdem SR; Deveci S; Verdi H; Ozkardeş H
Int J Impot Res; 2007; 19(2):149-53. PubMed ID: 16871271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
